Cargando…
Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs
Facing the continuous emergence of new psychoactive substances (NPS) and their threat to public health, more effective methods for NPS prediction and identification are critical. In this study, the pharmacological affinity fingerprints (Ph-fp) of NPS compounds were predicted by Random Forest classif...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171973/ https://www.ncbi.nlm.nih.gov/pubmed/35672835 http://dx.doi.org/10.1186/s13321-022-00607-6 |
_version_ | 1784721787801567232 |
---|---|
author | He, Kedan |
author_facet | He, Kedan |
author_sort | He, Kedan |
collection | PubMed |
description | Facing the continuous emergence of new psychoactive substances (NPS) and their threat to public health, more effective methods for NPS prediction and identification are critical. In this study, the pharmacological affinity fingerprints (Ph-fp) of NPS compounds were predicted by Random Forest classification models using bioactivity data from the ChEMBL database. The binary Ph-fp is the vector consisting of a compound’s activity against a list of molecular targets reported to be responsible for the pharmacological effects of NPS. Their performance in similarity searching and unsupervised clustering was assessed and compared to 2D structure fingerprints Morgan and MACCS (1024-bits ECFP4 and 166-bits SMARTS-based MACCS implementation of RDKit). The performance in retrieving compounds according to their pharmacological categorizations is influenced by the predicted active assay counts in Ph-fp and the choice of similarity metric. Overall, the comparative unsupervised clustering analysis suggests the use of a classification model with Morgan fingerprints as input for the construction of Ph-fp. This combination gives satisfactory clustering performance based on external and internal clustering validation indices. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13321-022-00607-6. |
format | Online Article Text |
id | pubmed-9171973 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-91719732022-06-08 Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs He, Kedan J Cheminform Research Article Facing the continuous emergence of new psychoactive substances (NPS) and their threat to public health, more effective methods for NPS prediction and identification are critical. In this study, the pharmacological affinity fingerprints (Ph-fp) of NPS compounds were predicted by Random Forest classification models using bioactivity data from the ChEMBL database. The binary Ph-fp is the vector consisting of a compound’s activity against a list of molecular targets reported to be responsible for the pharmacological effects of NPS. Their performance in similarity searching and unsupervised clustering was assessed and compared to 2D structure fingerprints Morgan and MACCS (1024-bits ECFP4 and 166-bits SMARTS-based MACCS implementation of RDKit). The performance in retrieving compounds according to their pharmacological categorizations is influenced by the predicted active assay counts in Ph-fp and the choice of similarity metric. Overall, the comparative unsupervised clustering analysis suggests the use of a classification model with Morgan fingerprints as input for the construction of Ph-fp. This combination gives satisfactory clustering performance based on external and internal clustering validation indices. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13321-022-00607-6. Springer International Publishing 2022-06-07 /pmc/articles/PMC9171973/ /pubmed/35672835 http://dx.doi.org/10.1186/s13321-022-00607-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article He, Kedan Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs |
title | Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs |
title_full | Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs |
title_fullStr | Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs |
title_full_unstemmed | Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs |
title_short | Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs |
title_sort | pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171973/ https://www.ncbi.nlm.nih.gov/pubmed/35672835 http://dx.doi.org/10.1186/s13321-022-00607-6 |
work_keys_str_mv | AT hekedan pharmacologicalaffinityfingerprintsderivedfrombioactivitydatafortheidentificationofdesignerdrugs |